Bibliografia di riferimento
- Baccarani M, Cavo M, Gobbi M, et al. Staginig of Chronic Lymphocytic Leukemia. Blood: 1982; 59: 1191-96.
- Bacigalupo A., Spriano M., F. Patrone, M. Gobbi, R. Ghio, M. Ferrarini, M. R. Sertoli, M. Carella, E. Damasio, G.Santini, E. Rossi, M. Spriano, M. Ratti "Linea guida su: Diagnosi e terapia della leucemia linfatica cronica" (http://www.regione.liguria.it/salusoc/1_sal/linee/linee11.htm#01)
- Bernasconi C e Pagnucco G Leucemia linfatica cronica: dalla chemioterapia convenzionale ai nuovi farmaci. Proceedings. 37th Congress of the Italian Society of Hematology, Turin, Italy, September 26-29, 1999
- Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of Chronic Lymphocytic Leukemia derived from multivariate survival analysis. Cancer 1981; 48:198-206
- Byrd J-C, Rai KR, Sausville Ea, Grever Mr Old and new Therapies in Chronic lymphocytic Leukemia: Now is the Time for a Reassessment of Therapeutic Goals. Sem. Oncol. 1998; 25:65-74
- Caligaris-Cappio F, Geuna M, Gottardi D, Granziero L, Circosta P, Ghia PP La B-leucemia linfatica cronica: caratteristiche biologiche. Proceedings. 37th Congress of the Italian Society of Hematology, Turin, Italy, September 26-29, 1999
- Chandra J. Niemer I., et al Proteasome inhibitors induce apoptosis in glucocorticoid,-resistant Chronic Lymphocytic Leukemic Lymphocytes. Blood 1998; 92: 4220-4229.
- Cheson BD, Bennet JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR National Cancer Institute-Working Group Guidelines for Chronic Lymphocytic Leukemia: Revised Guidelines for Diagnosisi and Treatment. Blood: 1996; 87:4990-97
- Criel A, Verhoef G, Vlietink R, et al. Further characterisation of morphologically defined typical and atypical CLL: a clinical immunophenotypic, cytogenetic and prognostic study on 390 cases. Br. J. Haematol 1997; 97:383-91
- Damle R. Wasdil T, Fais F, Ghiotto F, Valetto A, Allen S IgV mutation status and CD38+ expression as novel prognostic indicators in Chronic Lymphocytic Leukemias. Blood 1999; 94: 1840-47
- Dighiero G and Binet J-L "When and how to treat Chronic Lymphocytic Leukemia" The New England Journal of Medicine 2000; 343:24
- D'Onofrio - Zini "Morfologia del sangue" Verduci Editore, Roma 1997.
- Herold M., Shulze A. et al. Case report: successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD20 antibody. Annals of Hematol. 2000; 79: 332-335
- Masdehors P., Marle-Beral H. et al. Deregulation of the Ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL Lymphocytes. Blood 2000; 96: 269-274.
- Marti GE, Faguet G, Bertin P, et al. CD20 and CD5 expression in B-chronic lymphocytic leukemia.Ann NY Acad SCI. 1992; 651:480-483.
- Molica S, Aliberti A Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 1987; 60: 2712-16.
- Nguyen D and Diamond L; Diagnostic Hemathology. A Pattern Approach
- Pettitt AR, Sherrington PD, Cawley JC Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues Cancer res 2000 Aug 1; 60(15):4187-93
- Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of Chronic Lymphocytic Leukemia. Blood 1975; 46: 219-234.
- Rose NR, Conway de Macario E, Folds JD, Lane HC, Nakamura RM Manual of Clinical laboratory Immunology.
- Sivaraman S. Desphande C.G. et al. Tumor Necrosis Factor modulates CD 20 expression on cells from chronic limphocytic leukemia: a new role for TNF-alfa? Michrosc. Res. Tech. 2000; 50: 251-257.
- Zwiebel JA, Cheson BD Chronic lymphocytic Leukemia: staging and Prognostic Factors. Sem. Oncol 1998;25:42-59
